High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: Usefulness in laboratory diagnosis of human prion disease

BMC Neurology

Volumn 11, Issue , 2011, Pages

  Matsui, Yuki ^a   Satoh, Katsuya ^b   Miyazaki, Toshiaki ^c   Shirabe, Susumu ^b   Atarashi, Ryuichiro ^b   Mutsukura, Kazuo ^d   Satoh, Akira ^d   Kataoka, Yasufumi ^a   Nishida, Noriyuki ^b  

^a FUKUOKA UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c Cyclex   (Japan)

^d Nagasaki Kita Hospital   (Japan)

Author keywords

14 3 3 protein; CJD; CSF; ELISA; Prion disease; Tau protein

Indexed keywords

PROTEIN 14 3 3; PROTEIN 14 3 3 GAMMA PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIFFUSION WEIGHTED IMAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL CREUTZFELDT JAKOB DISEASE; FEMALE; HUMAN; IATROGENIC CREUTZFELDT JAKOB DISEASE; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; SPORADIC CREUTZFELDT JAKOB DISEASE; WESTERN BLOTTING; COMPARATIVE STUDY; CREUTZFELDT JAKOB DISEASE; EARLY DIAGNOSIS; METHODOLOGY; MIDDLE AGED; PREDICTIVE VALUE; STATISTICS;

14-3-3 PROTEINS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CREUTZFELDT-JAKOB SYNDROME; DIFFUSION MAGNETIC RESONANCE IMAGING; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TAU PROTEINS;

EID: 80053556213     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-11-120     Document Type: Article

References (10)

1. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. The New England journal of medicine 1996, 335(13):924-930. 10.1056/NEJM199609263351303, 8782499.
2. Brandel JP, Delasnerie-Laupretre N, Laplanche JL, Hauw JJ, Alperovitch A. Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology 2000, 54(5):1095-1099.
3. Satoh K, Tobiume M, Matsui Y, Mutsukura K, Nishida N, Shiga Y, Eguhchi K, Shirabe S, Sata T. Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease. Laboratory investigation; a journal of technical methods and pathology 2010, 90(11):1637-1644.3. 10.1038/labinvest.2009.68, 3184938, 21980241.
4. Kenney K, Brechtel C, Takahashi H, Kurohara K, Anderson P, Gibbs CJ. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Annals of neurology 2000, 48(3):395-398. 10.1002/1531-8249(200009)48:3<395::AID-ANA18>3.0.CO;2-A, 10976650.
5. Gmitterova K, Heinemann U, Bodemer M, Krasnianski A, Meissner B, Kretzschmar HA, Zerr I. 14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes. Neurobiology of aging 2009, 30(11):1842-1850. 10.1016/j.neurobiolaging.2008.01.007, 18328602.
6. Satoh K, Shirabe S, Tsujino A, Eguchi H, Motomura M, Honda H, Tomita I, Satoh A, Tsujihata M, Matsuo H, et al. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease. Dementia and geriatric cognitive disorders 2007, 24(3):207-212. 10.1159/000107082, 17690553.
7. Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T, Yamanaka H, Shirabe S, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nature medicine 2011, 17(2):175-178. 10.1038/nm.2294, 21278748.
8. Chohan G, Pennington C, Mackenzie JM, Andrews M, Everington D, Will RG, Knight RS, Green AJ. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. Journal of neurology, neurosurgery and psychiatry 2010, 81(11):1243-1248.
9. Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Saanchez-Valle R, Mitrovaa E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006, 67(4):637-643. 10.1212/01.wnl.0000230159.67128.00, 16924018.
10. Pennington C, Chohan G, Mackenzie J, Andrews M, Will R, Knight R, Green A. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease. Neuroscience letters 2009, 455(1):56-59. 10.1016/j.neulet.2009.02.067, 19429106.